StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Institutional Accumulation SZLS

<< Previous

Bullboard Posts

Next >>

Post by Photoman77on Sep 20, 2021 3:49pm

227 Views

Post# 33887619

Institutional Accumulation SZLS

Institutional Accumulation happening through Pershing Securities 143 & Fidelity 22

They have to have a few million shares now between the two.

Once the accumulation is done you will see the movement upwards.

Don't let them convince you otherwise.

Moniter for yourself here 9check out recent trades daily):

https://www.stockwatch.com/Quote/Detail?C:SZLS

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario